{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:06:49Z","timestamp":1789200409904,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010794","name":"Umea University Faculty of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"The Swedish Heart Lung Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002960","name":"Region V\u00e4sterbotten","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002960","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology Congenital Heart Disease"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijcchd.2026.100705","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T06:44:04Z","timestamp":1786603444000},"page":"100705","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Meta-analysis of RAAS inhibition in patients with a systemic right ventricle"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-3407-7646","authenticated-orcid":false,"given":"Yousef","family":"Baroudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10053","key":"10.1016\/j.ijcchd.2026.100705_bib1","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","article-title":"Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the global burden of disease study 2015","volume":"388","author":"Wang","year":"2016","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.ijcchd.2026.100705_bib2","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/j.jacc.2011.08.025","article-title":"Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis","volume":"58","author":"van der Linde","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"10.1016\/j.ijcchd.2026.100705_bib3","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1161\/CIRCULATIONAHA.110.946343","article-title":"Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium","volume":"122","author":"Moons","year":"2010","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ijcchd.2026.100705_bib4","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1001\/jamainternmed.2016.7765","article-title":"Survivorship in children and young adults with congenital heart disease in Sweden","volume":"177","author":"Mandalenakis","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"9","key":"10.1016\/j.ijcchd.2026.100705_bib5","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/CIRCULATIONAHA.113.008396","article-title":"Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010","volume":"130","author":"Marelli","year":"2014","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ijcchd.2026.100705_bib6","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1161\/CIRCULATIONAHA.117.031544","article-title":"Systemic right ventricle in adults with congenital heart disease: anatomic and phenotypic spectrum and current approach to management","volume":"137","author":"Brida","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.ijcchd.2026.100705_bib7","article-title":"Heart failure in systemic right ventricle: mechanisms and therapeutic options","volume":"9","author":"Sabbah","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"10.1016\/j.ijcchd.2026.100705_bib8","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/eurheartj\/ehaa554","article-title":"2020 ESC guidelines for the management of adult congenital heart disease","volume":"42","author":"Baumgartner","year":"2021","journal-title":"Eur Heart J"},{"issue":"36","key":"10.1016\/j.ijcchd.2026.100705_bib9","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"43","key":"10.1016\/j.ijcchd.2026.100705_bib10","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1093\/eurheartj\/ehaa701","article-title":"The ESC clinical practice guidelines for the management of adult congenital heart disease 2020","volume":"41","author":"Baumgartner","year":"2020","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.ijcchd.2026.100705_bib11","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jacc.2025.09.006","article-title":"2025 ACC\/AHA\/HRS\/ISACHD\/SCAI guideline for the management of adults with congenital heart disease: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"87","author":"Gurvitz","year":"2026","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ijcchd.2026.100705_bib12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/ehjcvp\/pvaa111","article-title":"Medication in adults after atrial switch for transposition of the great arteries: clinical practice and recommendations","volume":"8","author":"Woudstra","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"14","key":"10.1016\/j.ijcchd.2026.100705_bib13","doi-asserted-by":"crossref","first-page":"e801","DOI":"10.1161\/CIR.0000000000000604","volume":"139","author":"Zaragoza-Macias","year":"2019","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.ijcchd.2026.100705_bib14","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/eurheartj\/ehad890","article-title":"Angiotensin receptor-neprilysin inhibitor vs. placebo in congenital systemic right ventricular heart failure: the PARACYS-RV trial","volume":"45","author":"Chaix","year":"2024","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ijcchd.2026.100705_bib15","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.009848","article-title":"Safety and efficacy of sacubitril\/valsartan in patients with a failing systemic right ventricle: a prospective single-center study","volume":"16","author":"Fusco","year":"2023","journal-title":"Circ Heart Fail"},{"issue":"21","key":"10.1016\/j.ijcchd.2026.100705_bib16","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1136\/heartjnl-2020-318074","article-title":"Sacubitril\/Valsartan in the treatment of systemic right ventricular failure","volume":"107","author":"Zandstra","year":"2021","journal-title":"Heart"},{"issue":"20","key":"10.1016\/j.ijcchd.2026.100705_bib17","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1136\/heartjnl-2022-322332","article-title":"Tolerability and beneficial effects of sacubitril\/valsartan on systemic right ventricular failure","volume":"109","author":"Nederend","year":"2023","journal-title":"Heart"},{"key":"10.1016\/j.ijcchd.2026.100705_bib18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"10.1016\/j.ijcchd.2026.100705_bib19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijcard.2010.08.068","article-title":"Safety and efficiency of chronic ACE inhibition in symptomatic heart failure patients with a systemic right ventricle","volume":"154","author":"Tutarel","year":"2012","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.ijcchd.2026.100705_bib20","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/CIRCULATIONAHA.112.135392","article-title":"Effect of valsartan on systemic right ventricular function: a double-blind, randomized, placebo-controlled pilot trial","volume":"127","author":"van der Bom","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ijcchd.2026.100705_bib21","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijcard.2018.11.027","article-title":"Long-term clinical outcomes of valsartan in patients with a systemic right ventricle: follow-up of a multicenter randomized controlled trial","volume":"278","author":"van Dissel","year":"2019","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.ijcchd.2026.100705_bib22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijcard.2008.04.056","article-title":"Effect of angiotensin receptor blockade on systemic right ventricular function and size: a small, randomized, placebo-controlled study","volume":"129","author":"Therrien","year":"2008","journal-title":"Int J Cardiol"},{"issue":"16","key":"10.1016\/j.ijcchd.2026.100705_bib23","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1161\/CIRCULATIONAHA.105.543470","article-title":"Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricles: a multicenter, randomized, placebo-controlled clinical trial","volume":"112","author":"Dore","year":"2005","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ijcchd.2026.100705_bib24","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0002-9149(00)01452-1","article-title":"Angiotensin-converting enzyme inhibitors in adults after the mustard procedure","volume":"87","author":"Hechter","year":"2001","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.ijcchd.2026.100705_bib25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","author":"Investigators","year":"1991","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.ijcchd.2026.100705_bib26","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure. Results of the cooperative North Scandinavian Enalapril survival study (CONSENSUS)","volume":"316","year":"1987","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.ijcchd.2026.100705_bib27","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/S0735-1097(02)02304-5","article-title":"Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors","volume":"40","author":"Maggioni","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ijcchd.2026.100705_bib28","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/ejhf.1139","article-title":"Effect of sacubitril\/valsartan on recurrent events in the prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF)","volume":"20","author":"Mogensen","year":"2018","journal-title":"Eur J Heart Fail"},{"issue":"21","key":"10.1016\/j.ijcchd.2026.100705_bib29","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/j.ehj.2004.07.025","article-title":"Effect of candesartan on New York heart association functional class. Results of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme","volume":"25","author":"O'Meara","year":"2004","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.ijcchd.2026.100705_bib30","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcchd.2026.100705_bib31","series-title":"WHO guidelines approved by the Guidelines Review Committee. Geneva","year":"2021"}],"container-title":["International Journal of Cardiology Congenital Heart Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666668526000546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666668526000546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T07:48:45Z","timestamp":1789199325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666668526000546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":31,"alternative-id":["S2666668526000546"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcchd.2026.100705","relation":{},"ISSN":["2666-6685"],"issn-type":[{"value":"2666-6685","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meta-analysis of RAAS inhibition in patients with a systemic right ventricle","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology Congenital Heart Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcchd.2026.100705","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100705"}}